Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06270641 · ClinicalTrials.gov registry record · NA
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
A NA study of Fatigue and Physical Inactivity, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 1
- Study location
NCT06270641: Recruiting NA study of Fatigue and Physical Inactivity, sponsored by University of Washington.
NCT06270641 is a NA study of Fatigue and Physical Inactivity that is actively recruiting participants, run by University of Washington. The registered enrollment target is 106 participants, below the 217-participant average among 109 other Fatigue trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06270641, a NA study of Fatigue and Physical Inactivity, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to advance the scientific understanding and potential future implementation of physical activity promotion by testing the efficacy of a phone-based app for increasing activity in insufficiently active patients with multiple sclerosis (MS).
Primary Outcome
Increase in physical activity measured by daily average step count measured by ExerciseRx app. Increase in physical activity will be measured and compared between the ExerciseRx and usual care participants.
Conditions Studied
Interventions
- OTHER ExerciseRx intervention
Study Locations (1)
Washington
- UW Medicine - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2024-02-16 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT06270641 shows while recruiting
NCT06270641 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 217-participant average among 109 other Fatigue trials with a reported enrollment target (51% lower).
The record links to 3 conditions, with Fatigue appearing as the primary indexed condition, and to 1 intervention - of which ExerciseRx intervention is the first listed.
NCT06270641 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06270641 about?
NCT06270641 is a clinical study titled "Increasing Physical Activity for Adults With Multiple Sclerosis (MS)". This study aims to advance the scientific understanding and potential future implementation of physical activity promotion by testing the efficacy of a phone-based app for increasing activity in insufficiently active patients with multiple sclerosis (MS).
What is the current status of trial NCT06270641?
This trial is currently recruiting. It is a NA study. The enrollment target is 106 participants. The study started on 2024-02-16. Estimated completion is 2026-09-30.
What conditions does trial NCT06270641 study?
This clinical trial studies the following conditions: Fatigue, Physical Inactivity, Multiple Sclerosis, MS.
What interventions are being tested in trial NCT06270641?
The interventions under investigation include: ExerciseRx intervention (OTHER).
Who is sponsoring clinical trial NCT06270641?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06270641 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06270641's enrollment target sits among peer trials
106 38th of 109 higher than 72 of 109 other Fatigue trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fatigue and Cognitive Demand With Aging
RECRUITING · NA
-
Behavioral and Neural Correlates of Post-Stroke Fatigue
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
-
Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management
RECRUITING · NA
-
Active Living After Cancer: Implementation Within Be Well Acres Homes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI